DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Paz-Priel I, Chang T, Asikanius E. , et al.
Immunogenicity of emicizumab in people with hemophilia A (PwHA): results from the HAVEN 1–4 studies.
60th Annual Meeting of the American Society of Hematology (ASH) December 1–4, 2018 ; San Diego, CA
We do not assume any responsibility for the contents of the web pages of other providers.